应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
JNJ 强生
休市中 04-24 16:00:00 EDT
227.50
-3.15
-1.37%
盘后
227.48
-0.02
-0.01%
19:59 EDT
最高
229.99
最低
227.02
成交量
606.75万
今开
229.03
昨收
230.65
日振幅
1.29%
总市值
5,481亿
流通市值
5,470亿
总股本
24.09亿
成交额
13.83亿
换手率
0.25%
流通股本
24.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
强生(JNJ)拟收购Atraverse Medical 扩充心脏消融产品组合
金吾财讯 · 04-24 22:17
强生(JNJ)拟收购Atraverse Medical 扩充心脏消融产品组合
Imaavy®(Nipocalimab-Aahu)在广泛全身型重症肌无力患者群体中展现逾两年持续疾病控制
美股速递 · 04-22
Imaavy®(Nipocalimab-Aahu)在广泛全身型重症肌无力患者群体中展现逾两年持续疾病控制
美国法官驳回拜耳要求阻止强生前列腺癌药物索赔的申请
环球市场播报 · 04-18
美国法官驳回拜耳要求阻止强生前列腺癌药物索赔的申请
美国法官驳回拜耳禁令请求,禁止强生就前列腺癌药物发表涉嫌不实言论
美股速递 · 04-18
美国法官驳回拜耳禁令请求,禁止强生就前列腺癌药物发表涉嫌不实言论
强生与JJDc达成协议 MeiraGTx股票锁定期延长12个月
美股速递 · 04-16
强生与JJDc达成协议 MeiraGTx股票锁定期延长12个月
MeiraGTx Holdings Plc将向强生支付2500万美元首付款、里程碑款项及两位数高额特许权使用费以获取Bota-Vec权益
美股速递 · 04-16
MeiraGTx Holdings Plc将向强生支付2500万美元首付款、里程碑款项及两位数高额特许权使用费以获取Bota-Vec权益
巴克莱上调强生目标价至255美元
中金财经 · 04-16
巴克莱上调强生目标价至255美元
金佰利公布收购强生消费品公司Kenvue后的组织架构与领导团队
环球市场播报 · 04-16
金佰利公布收购强生消费品公司Kenvue后的组织架构与领导团队
抗癌药业务强劲 强生一季度销售额实现增长
环球市场播报 · 04-14
抗癌药业务强劲 强生一季度销售额实现增长
降价协议下大型药企韧性凸显 强生(JNJ.US)Q1业绩超预期并上调指引
智通财经 · 04-14
降价协议下大型药企韧性凸显 强生(JNJ.US)Q1业绩超预期并上调指引
强生(JNJ)Q1 Non-GAAP每股收益2.70美元超预期,营收240.6亿美元同比增长9.9%
金吾财讯 · 04-14
强生(JNJ)Q1 Non-GAAP每股收益2.70美元超预期,营收240.6亿美元同比增长9.9%
强生一季度销售额240.6亿美元,调整后每股收益2.70美元,均超预期
老虎资讯综合 · 04-14
强生一季度销售额240.6亿美元,调整后每股收益2.70美元,均超预期
强生连续第64年上调股息 季度分红提高3.1%创行业纪录
美股速递 · 04-14
强生连续第64年上调股息 季度分红提高3.1%创行业纪录
强生欧洲推出Varipulse Pro,推进脉冲电场消融产品组合
美股速递 · 04-07
强生欧洲推出Varipulse Pro,推进脉冲电场消融产品组合
财报前瞻|强生本季度营收预计增9.58%,机构观点偏乐观
财报Agent · 04-07
财报前瞻|强生本季度营收预计增9.58%,机构观点偏乐观
Inlexzo™(吉西他滨膀胱灌注系统)获永久计费代码,助力特定膀胱癌患者获取治疗
美股速递 · 04-02
Inlexzo™(吉西他滨膀胱灌注系统)获永久计费代码,助力特定膀胱癌患者获取治疗
强生(JNJ.US)1类新药在华获批临床 拟开发治疗骨髓增殖性肿瘤
智通财经 · 04-01
强生(JNJ.US)1类新药在华获批临床 拟开发治疗骨髓增殖性肿瘤
强生宣布Inlexzo永久性医保编码J码正式生效
美股速递 · 04-01
强生宣布Inlexzo永久性医保编码J码正式生效
强生Icotyde™(Icotrokinra)一年期数据证实:每日一次银屑病口服药可实现持久皮肤清除且安全性良好
美股速递 · 03-28
强生Icotyde™(Icotrokinra)一年期数据证实:每日一次银屑病口服药可实现持久皮肤清除且安全性良好
股价一年暴涨超700%的Nanobiotix(NBTX.US)迎来收购催化 强生(JNJ.US)有意出手
智通财经 · 03-25
股价一年暴涨超700%的Nanobiotix(NBTX.US)迎来收购催化 强生(JNJ.US)有意出手
加载更多
公司概况
公司名称:
强生
所属市场:
NYSE
上市日期:
--
主营业务:
强生公司于1887年在新泽西州注册成立,是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品,强调人类的健康和福祉。强生通过两个主要业务部门运营:创新药物和医疗技术。
发行价格:
--
{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":227.5,"timestamp":1777060800000,"preClose":230.65,"halted":0,"volume":6067521,"hourTrading":{"tag":"盘后","latestPrice":227.48,"preClose":227.5,"latestTime":"19:59 EDT","volume":740922,"amount":168558279.5953,"timestamp":1777075173377,"change":-0.02,"changeRate":-0.000088,"amplitude":0.002713},"delay":0,"changeRate":-0.01365705614567529,"floatShares":2404573193,"shares":2409295102,"eps":8.635366,"marketStatus":"休市中","change":-3.15,"latestTime":"04-24 16:00:00 EDT","open":229.03,"high":229.99,"low":227.02,"amount":1382654186.38674,"amplitude":0.012877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.635366,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":230.65,"dividendRate":0.022857,"preHourTrading":{"tag":"盘前","latestPrice":229.5,"preClose":230.65,"latestTime":"09:29 EDT","volume":11723,"amount":2685976.2218299997,"timestamp":1777037399336,"change":-1.15,"changeRate":-0.004986,"amplitude":0.027774},"postHourTrading":{"tag":"盘后","latestPrice":227.48,"preClose":227.5,"latestTime":"19:59 EDT","volume":740922,"amount":168558279.5953,"timestamp":1777075173377,"change":-0.02,"changeRate":-0.000088,"amplitude":0.002713},"volumeRatio":0.6859675283275062,"impliedVol":0.2496,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"2629684023","title":"强生(JNJ)拟收购Atraverse Medical 扩充心脏消融产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2629684023","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629684023?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:17","pubTimestamp":1777040254,"startTime":"0","endTime":"0","summary":"Atraverse Medical总部位于圣地亚哥,其HOTWIRE经隔膜入路系统于去年12月获得美国FDA批准,该系统基于射频技术,用于左心房入路,目前已应用于约3000例医疗手术。此次拟议收购预计将于 2026年第二季度完成,将进一步强化其心脏消融解决方案组合。据悉,强生心血管业务依托现有产品组合,2025年实现销售额89亿美元,同比增长约16%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299681","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2896262040.SGD","BK4581","LU0795875169.SGD","LU0098860793.USD","LU0689472784.USD","IE00BSNM7G36.USD","IE000M9KFDE8.USD","LU0432979614.USD","LU1732800096.USD","LU0345770993.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","BK4585","LU0289739699.SGD","LU0820562030.AUD","LU2750360997.AUD","LU1162221912.USD","LU2430703095.HKD","IE00B42XCP33.USD","LU0912757837.SGD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","LU1732799900.SGD","LU0114720955.EUR","LU2602419157.SGD","LU0122379950.USD","LU1057294990.SGD","IE00BFXG1179.USD","LU1718418525.SGD","LU1430594728.SGD","LU0820561909.HKD","BK4533","LU0985320562.USD","LU1145028129.USD","LU2129689431.USD","LU1674673428.USD","LU1280957306.USD","LU0426417589.USD","LU0964807845.USD","LU1066053197.SGD","JNJ","LU2471134796.USD","IE00B2B36J28.USD","LU1066051498.USD","BK4592","LU2471134952.CNY","LU0640476718.USD","LU1244550577.SGD","LU1221951046.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181775369","title":"Imaavy®(Nipocalimab-Aahu)在广泛全身型重症肌无力患者群体中展现逾两年持续疾病控制","url":"https://stock-news.laohu8.com/highlight/detail?id=1181775369","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181775369?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:14","pubTimestamp":1776860053,"startTime":"0","endTime":"0","summary":"Imaavy®(Nipocalimab-Aahu)在针对广泛全身型重症肌无力(GMG)患者群体的研究中,显示出持续超过两年的疾病控制效果。这一长期数据突显了该疗法在管理此种慢性自身免疫性疾病方面的持久潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1674673691.USD","LU0985320562.USD","LU0889566641.SGD","LU1043141123.HKD","LU0345770308.USD","LU1221951129.SGD","LU0792757196.USD","LU2505996681.GBP","LU1244550494.USD","IE00BN8TJ469.HKD","LU1145028129.USD","LU0320765646.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU2505996509.AUD","IE00BLSP4452.SGD","IE00BVYPNW00.USD","LU0820562030.AUD","IE000BZT7R73.USD","BK4007","IE0001KFT4U8.USD","IE00B42XCP33.USD","LU0795875086.SGD","LU2347655156.SGD","LU0882574055.USD","LU2471134952.CNY","LU1059921491.USD","LU1914381329.SGD","LU0426417589.USD","LU1221951046.USD","IE00B19Z3581.USD","BK4559","LU0432979614.USD","LU0689472784.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1032466523.USD","LU0234572021.USD","IE00BVYPNV92.GBP","LU0964807845.USD","IE00B1BXHZ80.USD","LU1121112475.USD","LU1162221912.USD","BK4568","LU1732800096.USD","LU0234570918.USD","LU0210536198.USD","LU1983299246.USD","LU2430703095.HKD","LU2430703178.SGD","LU2602419157.SGD","SG9999013999.USD","IE00B4R5TH58.HKD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","LU0820561818.USD","BK4532","LU1674673428.USD","BK4585","LU2592432038.USD","LU2089984988.USD","LU1032955483.USD","LU1551013342.USD","IE00BBT3K403.USD","LU0058720904.USD","LU1244550221.USD","LU2023250330.USD","SG9999002224.SGD","LU0466842654.USD","LU2471134879.HKD","SG9999002232.USD","IE0034235303.USD","LU0210528500.USD","LU1066051811.HKD","LU0820561909.HKD","LU0912757837.SGD","LU1057294990.SGD","LU2756315664.SGD","LU1267930813.SGD","BK4533","JNJ","LU1066051225.USD","LU1506573853.SGD","LU0345769631.USD","BK4504","LU2487616109.SGD","IE000M9KFDE8.USD","BK4592","IE000WAW04H5.SGD","LU1718418525.SGD","LU1261432733.SGD","BK4550","LU1244550577.SGD","IE00B3T34201.USD","LU1894683348.USD","LU2129689605.HKD","LU0122379950.USD","LU2129689514.USD","IE0009355771.USD","IE00BGHQF631.EUR","LU0683600562.USD","LU2129689431.USD","LU0345769128.USD","IE00B7SZLL34.SGD","LU1043141396.HKD","LU2750360641.GBP","LU1066053197.SGD","LU1778281490.HKD","LU0795875169.SGD","LU0426412945.USD","IE000MB6IJN5.SGD","LU1551013425.SGD","IE000F7OJYX1.SGD","LU1732799900.SGD","LU2213496289.HKD","IE0000B7K699.USD","SG9999001176.SGD","LU1280957306.USD","LU0203347892.USD","LU2896262040.SGD","LU2430703251.USD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU1929549753.HKD","LU2471134796.USD","LU1585245621.USD","LU0345770993.USD","LU1066051498.USD","LU0943347566.SGD","LU1023059063.AUD","BK4534","IE00B3PB1722.GBP","LU2468319806.SGD","LU1935042991.SGD","IE00BKVL7J92.USD","LU0098860793.USD","LU2750360997.AUD","IE0002270589.USD","LU2756315318.SGD","LU0053666078.USD","LU1430594728.SGD","LU0124676726.USD","LU0289739699.SGD","LU0787776722.HKD","IE00B2B36J28.USD","IE00BFXG1179.USD","LU1496350502.SGD","LU0994945656.USD","SG9999001440.SGD","SGXZ57979304.SGD","BK4581","LU0203345920.USD","LU1196500208.SGD","LU1629891620.HKD","SG9999001176.USD","LU1061106388.HKD","LU2133065610.SGD","LU0640476718.USD","IE0002141913.USD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU1894683264.USD","LU0070217475.USD","BK4588","LU2471134523.USD","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628800867","title":"美国法官驳回拜耳要求阻止强生前列腺癌药物索赔的申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2628800867","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628800867?lang=zh_cn&edition=full","pubTime":"2026-04-18 07:41","pubTimestamp":1776469260,"startTime":"0","endTime":"0","summary":"一名美国联邦法官驳回了拜耳提出的禁止强生发布其价值数十亿美元的药物可将前列腺癌死亡风险降低一半的虚假广告的请求。 在周五晚的裁决中,美国曼哈顿地区法官戴尔-何说,拜耳没有证明它有可能胜诉,其诉讼请求包括强生为其药物Erleada所做的宣传造成了无法弥补的伤害,并有可能削弱人们对拜耳自己的药物Nubeqa的信任。 拜耳和强生均未在盘后立即回应置评请求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-18/doc-inhuwnkh1665365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["JNJ","LU0114720955.EUR","IE00B4R5TH58.HKD","LU1066051498.USD","LU1674673428.USD","LU2602419157.SGD","BK4585","LU2430703178.SGD","IE00BVYPNV92.GBP","LU1894683264.USD","IE00BBT3K403.USD","LU1244550494.USD","LU0787776722.HKD","LU0689626769.HKD","LU1057294990.SGD","IE00B2B36J28.USD","LU0994945656.USD","LU0234570918.USD","LU1066053197.SGD","LU0098860793.USD","LU2750360997.AUD","LU2505996681.GBP","BK4568","LU0889566641.SGD","IE00BVYPNW00.USD","LU0234572021.USD","IE00B42XCP33.USD","IE00B3T34201.USD","LU0985320562.USD","BK4534","IE00B19Z3B42.SGD","SG9999001176.USD","LU2592432038.USD","LU0466842654.USD","LU1983299246.USD","SG9999002224.SGD","LU0058720904.USD","LU1778281490.HKD","LU1023059063.AUD","LU0122379950.USD","IE00BFXG1179.USD","LU0683600562.USD","LU0345770993.USD","SGXZ57979304.SGD","LU1043141123.HKD","LU1061106388.HKD","LU0124676726.USD","IE00BKVL7J92.USD","IE000WAW04H5.SGD","IE00B1BXHZ80.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136181753","title":"美国法官驳回拜耳禁令请求,禁止强生就前列腺癌药物发表涉嫌不实言论","url":"https://stock-news.laohu8.com/highlight/detail?id=1136181753","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136181753?lang=zh_cn&edition=full","pubTime":"2026-04-18 06:49","pubTimestamp":1776466151,"startTime":"0","endTime":"0","summary":"美国一名法官驳回了拜耳公司提出的禁令请求,该请求旨在阻止强生公司就前列腺癌药物发表涉嫌不实的言论。这一裁决意味着,强生目前可以继续其相关言论,而拜耳试图通过法律途径迅速阻止这些言论的努力未能成功。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985320562.USD","IE0002270589.USD","LU1718418525.SGD","IE00B3T34201.USD","LU0124676726.USD","LU1023059063.AUD","LU2750360997.AUD","BK4534","LU1244550494.USD","LU2505996509.AUD","LU1066051498.USD","LU2471134879.HKD","LU2468319806.SGD","LU1585245621.USD","LU1244550577.SGD","IE000MB6IJN5.SGD","BK4504","IE00BN8TJ469.HKD","LU0689626769.HKD","LU1732799900.SGD","LU2112291526.USD","LU2750360641.GBP","BK4588","SG9999001440.SGD","IE00B7SZLL34.SGD","LU0203347892.USD","LU0882574055.USD","LU1267930813.SGD","IE0002141913.USD","LU1221951129.SGD","LU2347655156.SGD","SG9999013999.USD","LU0795875169.SGD","LU2430703095.HKD","IE00BFXG1179.USD","LU0098860793.USD","LU0426412945.USD","LU0203345920.USD","BK4550","IE00B42XCP33.USD","BK4568","LU2602419157.SGD","IE00BGHQF631.EUR","LU0122379950.USD","LU2430703251.USD","IE00BVYPNV92.GBP","LU0345769631.USD","IE00BBT3K403.USD","LU0640476718.USD","LU1032955483.USD","LU0234570918.USD","IE0034235303.USD","LU2430703178.SGD","IE00BVYPNW00.USD","LU0432979614.USD","LU1280957306.USD","LU1032466523.USD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU0787776722.HKD","BK4581","IE00B19Z3B42.SGD","LU0070217475.USD","LU1061106388.HKD","LU1244550221.USD","LU1914381329.SGD","LU1074936037.SGD","LU1162221912.USD","LU1929549753.HKD","LU2592432038.USD","LU0994945656.USD","BK4007","LU0889566641.SGD","LU0912757837.SGD","IE00BZ1G4Q59.USD","LU1066051811.HKD","JNJ","SG9999002224.SGD","LU1732800096.USD","LU0795875086.SGD","LU1935042991.SGD","LU1674673691.USD","BK4585","LU2471134796.USD","LU0426417589.USD","LU0792757196.USD","LU0058720904.USD","LU2129689431.USD","LU0345769128.USD","LU0345770308.USD","LU0320765646.SGD","LU1674673428.USD","SG9999001176.USD","IE00B19Z3581.USD","BK4532","LU0683600562.USD","IE00BSNM7G36.USD","IE0001KFT4U8.USD","LU2505996681.GBP","LU0234572021.USD","LU2471134523.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1506573853.SGD","IE00BKVL7J92.USD","LU1496350502.SGD","IE00BDGV0183.EUR","LU2089984988.USD","BK4559","LU0289739699.SGD","LU0466842654.USD","IE0009355771.USD","LU1894683264.USD","LU2133065610.SGD","LU0345770993.USD","IE00BLSP4239.USD","LU1121112475.USD","LU1221951046.USD","BK4592","IE000F7OJYX1.SGD","SG9999002232.USD","IE00B3PB1722.GBP","LU2129689605.HKD","IE000WAW04H5.SGD","LU2129689514.USD","LU1778281490.HKD","LU1983299246.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","LU1043141123.HKD","LU1057294990.SGD","IE00B2B36J28.USD","IE000BZT7R73.USD","BK4533","LU1059921491.USD","LU1261432733.SGD","IE0000B7K699.USD","LU1043141396.HKD","LU2471134952.CNY","LU1196500208.SGD","LU0114720955.EUR","LU1066051225.USD","IE000SO60NU8.SGD","LU1894683348.USD","LU1066053197.SGD","LU1430594728.SGD","SGXZ57979304.SGD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126177328","title":"强生与JJDc达成协议 MeiraGTx股票锁定期延长12个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1126177328","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126177328?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:28","pubTimestamp":1776338880,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件显示,强生公司及其子公司JJDc已与基因疗法公司MeiraGTx Holdings Plc达成重要协议。双方约定在交易完成后的12个月内,对持有的MeiraGTx股票实施锁定期限制。\n这一锁定安排意味着相关方在此期间不得出售或转让其持有的MeiraGTx股份。该举措通常被视为对公司长期发展前景的信心表现,有助于维护股价稳定和市场信心。\n作为基因治疗领域的知名企业,MeiraGTx专注于开发针对严重疾病的新型疗法。此次锁定期协议的达成,标志着合作双方战略伙伴关系的进一步深化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","IE00BN8TJ469.HKD","LU0787776722.HKD","LU1196500208.SGD","IE000F7OJYX1.SGD","BK4550","LU0345769128.USD","LU2430703095.HKD","LU1059921491.USD","LU1066051225.USD","LU1935042991.SGD","IE00B19Z3B42.SGD","LU2471134952.CNY","IE0034235303.USD","LU0114720955.EUR","BK4504","LU1221951129.SGD","SG9999001176.SGD","LU0795875169.SGD","LU0792757196.USD","LU0985320562.USD","LU2505996681.GBP","LU0058720904.USD","LU2430703178.SGD","LU1221951046.USD","IE00BLSP4452.SGD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU0994945656.USD","LU2471134796.USD","LU1496350502.SGD","LU1280957306.USD","LU0124676726.USD","LU0234572021.USD","LU0098860793.USD","SG9999001440.SGD","IE00B3PB1722.GBP","LU0795875086.SGD","LU1430594728.SGD","IE00B3T34201.USD","LU2129689514.USD","LU2129689605.HKD","LU1894683264.USD","SG9999013999.USD","BK4534","LU0320765646.SGD","IE00B7SZLL34.SGD","SG9999002232.USD","LU0683600562.USD","LU0689626769.HKD","IE00BZ1G4Q59.USD","BK4568","LU1066053197.SGD","LU2347655156.SGD","BK4139","IE0002270589.USD","LU1023059063.AUD","LU2505996509.AUD","LU1585245621.USD","LU1778281490.HKD","IE0009355771.USD","LU0345770308.USD","IE00BVYPNV92.GBP","IE000M9KFDE8.USD","BK4585","LU1732800096.USD","IE00BBT3K403.USD","LU1074936037.SGD","IE00BVYPNW00.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU1914381329.SGD","LU2750360641.GBP","LU0234570918.USD","IE0002141913.USD","LU1674673691.USD","BK4559","IE00B1BXHZ80.USD","SG9999001176.USD","LU2750360997.AUD","LU1929549753.HKD","LU2133065610.SGD","LU1043141396.HKD","IE00BJJMRZ35.SGD","LU1121112475.USD","IE000MB6IJN5.SGD","LU1032955483.USD","LU1066051811.HKD","LU2129689431.USD","LU1894683348.USD","LU0426412945.USD","LU1506573853.SGD","IE000SO60NU8.SGD","IE000BZT7R73.USD","LU0122379950.USD","LU1244550221.USD","LU1244550577.SGD","MGTX","LU2112291526.USD","BK4532","LU0203345920.USD","JNJ","LU0640476718.USD","IE00BJT1NW94.SGD","LU0345770993.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","IE00BDGV0183.EUR","IE00BKVL7J92.USD","LU2471134523.USD","LU1732799900.SGD","LU0882574055.USD","IE00B19Z3581.USD","LU0203347892.USD","LU2471134879.HKD","LU2089984988.USD","BK4592","SG9999002224.SGD","LU1267930813.SGD","LU2430703251.USD","LU1674673428.USD","LU1162221912.USD","IE00B42XCP33.USD","LU0466842654.USD","IE0001KFT4U8.USD","LU1261432733.SGD","LU1032466523.USD","IE00BFXG1179.USD","IE000WAW04H5.SGD","LU2592432038.USD","LU1061106388.HKD","LU1244550494.USD","IE0000B7K699.USD","BK4533","LU0070217475.USD","LU0432979614.USD","LU1066051498.USD","LU1983299246.USD","LU1043141123.HKD","BK4007","BK4588","LU0426417589.USD","LU1057294990.SGD","LU1718418525.SGD","LU0889566641.SGD","IE00BGHQF631.EUR","LU2602419157.SGD","LU2468319806.SGD","IE00BLSP4239.USD","BK4581","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182348159","title":"MeiraGTx Holdings Plc将向强生支付2500万美元首付款、里程碑款项及两位数高额特许权使用费以获取Bota-Vec权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1182348159","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182348159?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:11","pubTimestamp":1776337896,"startTime":"0","endTime":"0","summary":"生物技术公司MeiraGTx Holdings Plc与医疗保健巨头强生达成一项关于基因疗法Bota-Vec的授权协议。根据协议条款,MeiraGTx将向强生支付包括2500万美元首付款、后续里程碑款项以及高达两位数百分比的特许权使用费在内的多重财务对价。高额的特许权使用费条款凸显了该疗法在商业化后的潜在市场价值。通过获得Bota-Vec的权益,MeiraGTx有望进一步拓展其基因治疗产品管线。而对于强生而言,此次授权交易则体现了其通过外部合作优化研发资产组合的战略方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU1929549753.HKD","IE0034235303.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU2602419157.SGD","LU2133065610.SGD","LU0792757196.USD","LU0994945656.USD","LU0882574055.USD","IE000WAW04H5.SGD","BK4588","LU1066051811.HKD","LU0426417589.USD","LU1506573853.SGD","LU0985320562.USD","LU1221951046.USD","LU1066051498.USD","LU0787776722.HKD","LU2750360641.GBP","BK4559","LU0683600562.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0124676726.USD","IE00BBT3K403.USD","LU0889566641.SGD","BK4139","LU1732799900.SGD","LU0689626769.HKD","IE00B42XCP33.USD","SG9999002232.USD","SG9999001176.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU2468319806.SGD","LU2430703251.USD","LU1059921491.USD","BK4568","IE000SO60NU8.SGD","IE00BVYPNW00.USD","LU1261432733.SGD","SGXZ57979304.SGD","IE00BGHQF631.EUR","LU1066051225.USD","LU2505996681.GBP","SG9999002224.SGD","LU1244550221.USD","LU2129689514.USD","LU1244550577.SGD","LU1043141123.HKD","LU1496350502.SGD","BK4504","LU0122379950.USD","LU0203345920.USD","LU2750360997.AUD","LU2347655156.SGD","IE000M9KFDE8.USD","IE00BFXG1179.USD","LU0345770993.USD","IE00BJJMRZ35.SGD","LU2430703095.HKD","LU2471134952.CNY","LU0466842654.USD","LU0795875169.SGD","LU1718418525.SGD","BK4581","LU1914381329.SGD","BK4007","IE00BN8TJ469.HKD","BK4585","LU1894683348.USD","IE00BLSP4239.USD","LU0912757837.SGD","LU1732800096.USD","LU0203347892.USD","IE0009355771.USD","LU2112291526.USD","LU2430703178.SGD","LU0345769128.USD","SG9999001176.USD","IE00B2B36J28.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU1244550494.USD","IE0002270589.USD","LU0234570918.USD","LU1585245621.USD","IE0001KFT4U8.USD","LU0234572021.USD","LU0289739699.SGD","IE00B3PB1722.GBP","BK4533","IE000F7OJYX1.SGD","LU0432979614.USD","LU0058720904.USD","LU0795875086.SGD","BK4550","IE000BZT7R73.USD","LU1221951129.SGD","IE00BSNM7G36.USD","LU0426412945.USD","BK4534","IE0000B7K699.USD","LU1280957306.USD","LU1674673691.USD","LU1061106388.HKD","LU1894683264.USD","LU1043141396.HKD","LU1674673428.USD","LU2129689431.USD","JNJ","IE00BDGV0183.EUR","LU1778281490.HKD","IE000MB6IJN5.SGD","LU1066053197.SGD","IE00B1BXHZ80.USD","LU2471134879.HKD","LU1121112475.USD","IE00BJT1NW94.SGD","LU2471134796.USD","LU1196500208.SGD","MGTX","LU0070217475.USD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU2592432038.USD","LU0345769631.USD","LU1032955483.USD","LU1162221912.USD","SG9999013999.USD","LU0114720955.EUR","LU1032466523.USD","LU0640476718.USD","IE0002141913.USD","LU1935042991.SGD","LU2505996509.AUD","IE00BFTCPJ56.SGD","IE00BVYPNV92.GBP","LU2089984988.USD","LU0098860793.USD","LU2129689605.HKD","LU1057294990.SGD","LU0320765646.SGD","BK4532","LU2471134523.USD","IE00BLSP4452.SGD","BK4592","LU0345770308.USD","LU1267930813.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627262894","title":"巴克莱上调强生目标价至255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627262894","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627262894?lang=zh_cn&edition=full","pubTime":"2026-04-16 14:57","pubTimestamp":1776322622,"startTime":"0","endTime":"0","summary":"巴克莱将强生的目标价从234美元上调至255美元,维持“持股观望”评级。(格隆汇)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260416/32147873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["JNJ","UUP","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627823604","title":"金佰利公布收购强生消费品公司Kenvue后的组织架构与领导团队","url":"https://stock-news.laohu8.com/highlight/detail?id=2627823604","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627823604?lang=zh_cn&edition=full","pubTime":"2026-04-16 00:18","pubTimestamp":1776269880,"startTime":"0","endTime":"0","summary":" 金佰利为其与 Kenvue 的合并后公司确定了组织架构,并任命了核心高管。此项收购预计将于今年晚些时候完成。 合并后的公司将囊括舒洁纸巾、好奇纸尿裤等消费品品牌,以及泰诺、李施德林等非处方产品品牌,并将按照四大地理业务板块运营。 金佰利首席执行官许森将领导合并后的新公司。 金佰利于去年 11 月同意以超400 亿美元的价格收购 Kenvue。公司表示,在获得监管批准及满足常规交割条件后,此项交易仍按计划于2026 年下半年完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-16/doc-inhurayy4488146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1280957306.USD","IE0001KFT4U8.USD","LU1914381329.SGD","LU1983299246.USD","JNJ","IE00B4R5TH58.HKD","LU0345770308.USD","LU1674673691.USD","LU2602419157.SGD","BK4007","LU1929549753.HKD","LU2463526074.USD","IE0002141913.USD","KMB","LU0098860793.USD","LU1032466523.USD","IE00B1BXHZ80.USD","LU2430703095.HKD","IE00BFTCPJ56.SGD","BK4585","LU0124676726.USD","BK4534","LU1074936037.SGD","LU1496350502.SGD","LU1585245621.USD","IE000BZT7R73.USD","IE0034235303.USD","IE00B2B36J28.USD","IE00BBT3K403.USD","LU1267930813.SGD","LU2505996509.AUD","IE00B3PB1722.GBP","LU1061106388.HKD","BK4532","IE000SO60NU8.SGD","IE00BJT1NW94.SGD","LU1043141396.HKD","LU1162221912.USD","SGXZ57979304.SGD","IE00B3T34201.USD","LU2471134879.HKD","BK4533","BK4550","LU1506573853.SGD","LU2089984988.USD","LU2750360641.GBP","LU0994945656.USD","LU1066051225.USD","LU0787776722.HKD","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627744196","title":"抗癌药业务强劲 强生一季度销售额实现增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2627744196","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627744196?lang=zh_cn&edition=full","pubTime":"2026-04-14 21:12","pubTimestamp":1776172320,"startTime":"0","endTime":"0","summary":" 强生一季度营收增长近 10%,达 240.6 亿美元;抗癌药销量走高,抵消了喜达妥 60% 的销量跌幅。 医疗健康巨头强生最新季度营收增长近 10%,主要得益于抗癌药销量强劲,抵消了旗下爆款药物喜达妥销量大幅下滑带来的影响。 强生公布一季度销售额升至240.6 亿美元,高于财经数据机构 FactSet 分析师平均预期的 236.2 亿美元。截至目前,伊朗冲突带来的扰动并未对强生造成实质性冲击。公司抗癌药业务本季度销量同比增长超 22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-14/doc-inhunpms4745575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0689626769.HKD","LU2471134952.CNY","IE00BGHQF631.EUR","LU0426412945.USD","LU1244550221.USD","LU2430703251.USD","LU1674673428.USD","LU2471134879.HKD","SG9999001440.SGD","LU1057294990.SGD","LU1074936037.SGD","LU0792757196.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","SG9999001176.USD","LU0234570918.USD","IE0000B7K699.USD","IE00BDGV0183.EUR","IE00BFXG1179.USD","LU0426417589.USD","LU1244550494.USD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LU2347655156.SGD","IE00BLSP4452.SGD","LU0098860793.USD","LU1066051811.HKD","LU0432979614.USD","LU1506573853.SGD","LU2471134523.USD","IE00BN8TJ469.HKD","LU1059921491.USD","BK4588","LU0882574055.USD","LU2602419157.SGD","LU2430703095.HKD","LU1043141123.HKD","LU1496350502.SGD","LU2505996509.AUD","IE00BVYPNV92.GBP","IE000M9KFDE8.USD","LU2129689605.HKD","IE00BBT3K403.USD","LU0985320562.USD","IE000MB6IJN5.SGD","LU2750360641.GBP","LU1032466523.USD","BK4581","JNJ","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627978443","title":"降价协议下大型药企韧性凸显 强生(JNJ.US)Q1业绩超预期并上调指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2627978443","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627978443?lang=zh_cn&edition=full","pubTime":"2026-04-14 19:30","pubTimestamp":1776166236,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,强生公布的第一季度销售额超出市场预期,并上调了全年业绩指引,这主要得益于新型癌症药物和抑郁症药物销售额的强劲增长。财报显示,强生第一季度销售额同比增长9.9%,至241亿美元,好于市场预期;经调整后每股收益为2.70美元,也好于市场预期。强生稳健的第一季度财报表明,尽管强生及其竞争对手与白宫达成降低部分药品价格的协议,但这些大型制药企业仍保持了良好的发展态势。财报公布后,强生股价盘前跌1.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4550","LU1057294990.SGD","LU1935042991.SGD","LU1261432733.SGD","LU2471134879.HKD","SG9999013999.USD","LU2089984988.USD","LU0882574055.USD","LU2468319806.SGD","IE0034235303.USD","LU1929549753.HKD","BK4532","LU0098860793.USD","BK4504","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU2430703178.SGD","IE0002270589.USD","LU1244550494.USD","LU1221951046.USD","JNJ","LU1506573853.SGD","LU1496350502.SGD","IE00BBT3K403.USD","IE00BGHQF631.EUR","BK4581","BK4533","LU0795875169.SGD","LU0466842654.USD","LU1043141396.HKD","LU0985320562.USD","BK4559","LU0426412945.USD","LU0640476718.USD","LU0345770308.USD","LU1244550577.SGD","IE00BJJMRZ35.SGD","LU0345770993.USD","LU2129689605.HKD","LU2505996681.GBP","LU0345769128.USD","IE00B19Z3B42.SGD","SG9999002232.USD","LU0058720904.USD","LU1066051811.HKD","LU1674673428.USD","IE00BVYPNV92.GBP","LU1674673691.USD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627448068","title":"强生(JNJ)Q1 Non-GAAP每股收益2.70美元超预期,营收240.6亿美元同比增长9.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627448068","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627448068?lang=zh_cn&edition=full","pubTime":"2026-04-14 19:19","pubTimestamp":1776165554,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生公司 发布 2026 年第一季度财报,公司非公认会计原则每股收益为 2.70 美元,较市场预期的 2.68 美元高出 0.02 美元;一季度营收达 240.6 亿美元,同比增长 9.9%,超过市场预期的 236.1 亿美元。此外,公司宣布将于 2026 年 12 月 8 日举办企业业务回顾会议,并将季度股息上调 3.1% 至 1.34 美元,股息将于 6 月 9 日支付,股权登记日为 5 月 26 日。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/N2I5NmMxMDRhMjE5ZjZkNDA5NWY5Njk1NzgzMjA0MDcxNDc1OTcyMzk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/N2I5NmMxMDRhMjE5ZjZkNDA5NWY5Njk1NzgzMjA0MDcxNDc1OTcyMzk=.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"479b43a272d0cf047ab2e6dcde3e2688","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299163","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125327753","title":"强生一季度销售额240.6亿美元,调整后每股收益2.70美元,均超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1125327753","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125327753?lang=zh_cn&edition=full","pubTime":"2026-04-14 18:22","pubTimestamp":1776162150,"startTime":"0","endTime":"0","summary":"预计全年销售额1,003亿美元至1,013亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/6c5786c8fa85dd12c89e99b2f6d9b92b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6c5786c8fa85dd12c89e99b2f6d9b92b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"479b43a272d0cf047ab2e6dcde3e2688","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"强生一季度销售额240.6亿美元,调整后每股收益2.70美元,均超预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134135863","title":"强生连续第64年上调股息 季度分红提高3.1%创行业纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=1134135863","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134135863?lang=zh_cn&edition=full","pubTime":"2026-04-14 18:21","pubTimestamp":1776162107,"startTime":"0","endTime":"0","summary":"医疗保健巨头强生公司再次展现其稳健的财务实力,宣布实现连续第64个年度的股息增长,将季度股息上调3.1%。本次股息调整后,强生每股季度现金股息提升至1.24美元,较此前1.19美元的水平有所增长。值得注意的是,强生此次股息增长恰逢公司进行业务重组的关键时期。作为道琼斯工业平均指数的成分股,强生长期稳定的股息政策使其成为价值投资者青睐的防御型标的。截至目前,强生已是标普500指数中连续提高股息年限最长的企业之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU0203345920.USD","LU1732800096.USD","SG9999001440.SGD","LU0640476718.USD","LU1894683264.USD","IE000M9KFDE8.USD","SG9999002224.SGD","LU2347655156.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE0009355771.USD","LU1221951046.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU0234570918.USD","IE00B7SZLL34.SGD","IE00BVYPNV92.GBP","LU2430703095.HKD","IE000BZT7R73.USD","LU0345770993.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU0882574055.USD","LU2112291526.USD","BK4592","LU1059921491.USD","IE00B1BXHZ80.USD","LU1162221912.USD","LU0426417589.USD","LU1061106388.HKD","SG9999001176.SGD","IE0002270589.USD","LU2129689605.HKD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU1674673428.USD","LU0320765646.SGD","BK4532","LU0795875086.SGD","IE000F7OJYX1.SGD","LU1066051811.HKD","LU2471134523.USD","IE000MB6IJN5.SGD","LU1074936037.SGD","BK4581","LU1066051498.USD","LU1929549753.HKD","LU2471134879.HKD","LU0994945656.USD","LU2468319806.SGD","LU2592432038.USD","LU2505996681.GBP","LU1066053197.SGD","LU0683600562.USD","LU1121112475.USD","IE00B3T34201.USD","BK4585","LU1244550494.USD","LU1280957306.USD","IE00BGHQF631.EUR","LU0689626769.HKD","SG9999013999.USD","JNJ","LU2129689431.USD","LU1221951129.SGD","LU0124676726.USD","LU0234572021.USD","IE000WAW04H5.SGD","IE00BSNM7G36.USD","LU0122379950.USD","BK4588","LU2750360997.AUD","LU0098860793.USD","SG9999001176.USD","LU1043141123.HKD","LU2471134952.CNY","LU1066051225.USD","IE0001KFT4U8.USD","LU1244550577.SGD","IE00BDGV0183.EUR","BK4550","LU1506573853.SGD","LU0432979614.USD","LU1935042991.SGD","LU2129689514.USD","LU2133065610.SGD","LU2505996509.AUD","LU1983299246.USD","LU0345769128.USD","BK4534","LU1732799900.SGD","SG9999002232.USD","LU0289739699.SGD","LU0345769631.USD","SGXZ57979304.SGD","LU0889566641.SGD","LU1894683348.USD","LU2089984988.USD","LU1496350502.SGD","LU1261432733.SGD","IE00BZ1G4Q59.USD","LU1718418525.SGD","IE00BKVL7J92.USD","LU2750360641.GBP","LU1196500208.SGD","IE0000B7K699.USD","IE00B42XCP33.USD","LU0787776722.HKD","LU0466842654.USD","LU2602419157.SGD","LU1032955483.USD","BK4504","LU0426412945.USD","IE000SO60NU8.SGD","LU0070217475.USD","LU2430703251.USD","LU0345770308.USD","LU0985320562.USD","LU2430703178.SGD","BK4533","LU2471134796.USD","LU1914381329.SGD","LU1674673691.USD","IE00B4R5TH58.HKD","LU0058720904.USD","LU0792757196.USD","BK4568","IE00BLSP4239.USD","IE00BJT1NW94.SGD","LU0795875169.SGD","IE0034235303.USD","LU0114720955.EUR","BK4559","LU1244550221.USD","IE00BVYPNW00.USD","LU1778281490.HKD","IE00B19Z3581.USD","LU0912757837.SGD","LU1032466523.USD","IE00B3PB1722.GBP","BK4007","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","LU1430594728.SGD","IE00BBT3K403.USD","LU0203347892.USD","LU1043141396.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184072442","title":"强生欧洲推出Varipulse Pro,推进脉冲电场消融产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1184072442","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184072442?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:01","pubTimestamp":1775563303,"startTime":"0","endTime":"0","summary":"强生公司通过在欧洲市场推出Varipulse Pro产品,进一步拓展了其脉冲电场消融技术产品线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1674673691.USD","LU0985320562.USD","LU0889566641.SGD","LU1043141123.HKD","LU0345770308.USD","LU1221951129.SGD","LU0792757196.USD","LU2505996681.GBP","LU1244550494.USD","IE00BN8TJ469.HKD","LU0320765646.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU2505996509.AUD","IE00BLSP4452.SGD","IE00BVYPNW00.USD","IE000BZT7R73.USD","BK4007","IE0001KFT4U8.USD","IE00B42XCP33.USD","LU0795875086.SGD","LU2347655156.SGD","LU0882574055.USD","LU2471134952.CNY","LU1059921491.USD","LU1914381329.SGD","LU0426417589.USD","LU1221951046.USD","IE00B19Z3581.USD","BK4559","LU0432979614.USD","LU1121112475.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1032466523.USD","LU0234572021.USD","IE00BVYPNV92.GBP","IE00B1BXHZ80.USD","LU1162221912.USD","BK4568","LU1732800096.USD","LU0234570918.USD","LU1983299246.USD","LU2430703095.HKD","LU2430703178.SGD","LU2602419157.SGD","IE00B4R5TH58.HKD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","LU1674673428.USD","BK4532","BK4585","LU2592432038.USD","LU2089984988.USD","LU1032955483.USD","IE00BBT3K403.USD","LU0058720904.USD","LU1244550221.USD","SG9999002224.SGD","LU0466842654.USD","LU2471134879.HKD","SG9999002232.USD","IE0034235303.USD","LU1066051811.HKD","LU0912757837.SGD","LU1057294990.SGD","LU1267930813.SGD","BK4533","JNJ","LU1066051225.USD","LU1506573853.SGD","LU0345769631.USD","BK4504","IE000M9KFDE8.USD","BK4592","IE000WAW04H5.SGD","LU1718418525.SGD","LU1261432733.SGD","BK4550","LU1244550577.SGD","IE00B3T34201.USD","LU1894683348.USD","LU2129689605.HKD","LU0122379950.USD","LU2129689514.USD","IE0009355771.USD","IE00BGHQF631.EUR","LU0683600562.USD","LU2129689431.USD","LU0345769128.USD","IE00B7SZLL34.SGD","LU1043141396.HKD","LU2750360641.GBP","LU1066053197.SGD","LU1778281490.HKD","LU0795875169.SGD","LU0426412945.USD","IE000MB6IJN5.SGD","IE000F7OJYX1.SGD","LU1732799900.SGD","IE0000B7K699.USD","LU1280957306.USD","LU0203347892.USD","LU2430703251.USD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU1929549753.HKD","LU2471134796.USD","LU1585245621.USD","LU0345770993.USD","LU1066051498.USD","LU1023059063.AUD","BK4534","IE00B3PB1722.GBP","LU2468319806.SGD","LU1935042991.SGD","IE00BKVL7J92.USD","LU0098860793.USD","LU2750360997.AUD","IE0002270589.USD","LU1430594728.SGD","LU0124676726.USD","LU0289739699.SGD","LU0787776722.HKD","IE00B2B36J28.USD","IE00BFXG1179.USD","LU1496350502.SGD","LU0994945656.USD","SG9999001440.SGD","BK4581","LU0203345920.USD","LU1196500208.SGD","LU1061106388.HKD","LU2133065610.SGD","LU0640476718.USD","IE0002141913.USD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU1894683264.USD","LU0070217475.USD","BK4588","LU2471134523.USD","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197066810","title":"财报前瞻|强生本季度营收预计增9.58%,机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1197066810","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197066810?lang=zh_cn&edition=full","pubTime":"2026-04-07 08:04","pubTimestamp":1775520278,"startTime":"0","endTime":"0","summary":"强生将于2026年04月14日美股盘前发布财报,市场聚焦创新药放量与医疗技术延续增长对营收与盈利的拉动效应。上季度公司营收为245.64亿美元,同比增长9.08%;毛利率为68.20%;归属于母公司股东的净利润为51.16亿美元,净利率为20.83%;调整后每股收益为2.46美元,同比增长20.59%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|强生本季度营收预计增9.58%,机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1118549304","title":"Inlexzo™(吉西他滨膀胱灌注系统)获永久计费代码,助力特定膀胱癌患者获取治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1118549304","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118549304?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:51","pubTimestamp":1775062274,"startTime":"0","endTime":"0","summary":"Inlexzo™(吉西他滨膀胱灌注系统)近日被授予永久性计费代码,这一关键进展将为特定类型的膀胱癌患者拓宽治疗可及性。永久代码的落地不仅简化了报销流程,更标志着该创新疗法在临床应用与保险覆盖层面获得制度化认可。医疗系统对精准化膀胱癌解决方案的需求日益增长,此次编码确立有望加速药物普及,让更多患者受益于前沿治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0001KFT4U8.USD","SG9999002224.SGD","LU2129689514.USD","LU2089984988.USD","LU0345769631.USD","LU2430703251.USD","IE0002141913.USD","IE00B7SZLL34.SGD","LU1066051811.HKD","IE00B4R5TH58.HKD","LU2129689431.USD","LU2129689605.HKD","LU1196500208.SGD","LU2505996681.GBP","JNJ","LU1496350502.SGD","LU0689626769.HKD","LU1032955483.USD","LU1894683264.USD","BK4550","LU2471134952.CNY","IE00BN8TJ469.HKD","LU0426412945.USD","LU0889566641.SGD","LU1043141123.HKD","SG9999002232.USD","LU1244550494.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1506573853.SGD","LU0882574055.USD","LU2112291526.USD","LU0122379950.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","LU0345770308.USD","LU0058720904.USD","BK4534","IE00B19Z3B42.SGD","LU0792757196.USD","LU0345770993.USD","LU0787776722.HKD","LU1023059063.AUD","SG9999001440.SGD","LU0683600562.USD","LU0994945656.USD","BK4533","BK4592","LU1221951129.SGD","IE00BDGV0183.EUR","LU1894683348.USD","IE00B3PB1722.GBP","LU1066053197.SGD","LU1066051498.USD","LU2505996509.AUD","LU1244550221.USD","LU1261432733.SGD","LU2750360641.GBP","LU1732800096.USD","IE00BKVL7J92.USD","LU2133065610.SGD","LU0070217475.USD","LU2471134523.USD","IE00BVYPNV92.GBP","LU0985320562.USD","LU0234570918.USD","LU0426417589.USD","LU0795875169.SGD","LU2347655156.SGD","IE00B19Z3581.USD","LU1430594728.SGD","LU1585245621.USD","LU1244550577.SGD","LU1718418525.SGD","IE00B2B36J28.USD","LU2471134796.USD","LU1059921491.USD","IE00BBT3K403.USD","LU2592432038.USD","LU1914381329.SGD","IE0009355771.USD","LU1778281490.HKD","LU0466842654.USD","LU1732799900.SGD","LU2430703095.HKD","LU0640476718.USD","BK4532","LU0912757837.SGD","LU1221951046.USD","BK4504","LU0203345920.USD","LU0345769128.USD","LU1066051225.USD","BK4007","IE00BFXG1179.USD","LU0203347892.USD","LU2468319806.SGD","LU1032466523.USD","IE00BZ1G4Q59.USD","BK4568","LU0114720955.EUR","LU0289739699.SGD","LU0795875086.SGD","LU0234572021.USD","LU1121112475.USD","IE00BLSP4452.SGD","LU1074936037.SGD","LU1935042991.SGD","LU2430703178.SGD","BK4559","IE00BJJMRZ35.SGD","LU1983299246.USD","BK4585","IE000M9KFDE8.USD","IE0034235303.USD","LU1674673691.USD","IE00BVYPNW00.USD","BK4588","LU1162221912.USD","IE00B42XCP33.USD","LU1061106388.HKD","IE0002270589.USD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1043141396.HKD","LU2602419157.SGD","LU2750360997.AUD","IE00BJT1NW94.SGD","BK4581","LU0124676726.USD","LU1267930813.SGD","LU0098860793.USD","LU0432979614.USD","LU1929549753.HKD","LU2471134879.HKD","IE00BGHQF631.EUR","LU0320765646.SGD","LU1280957306.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624519326","title":"强生(JNJ.US)1类新药在华获批临床 拟开发治疗骨髓增殖性肿瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2624519326","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624519326?lang=zh_cn&edition=full","pubTime":"2026-04-01 21:08","pubTimestamp":1775048929,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月31日,中国国家药监局药品审评中心官网公示显示,强生申报的1类新药JNJ-88549968注射液获批临床,拟开发治疗骨髓增殖性肿瘤。本次该产品在中国获批临床,意味着其即将开展针对骨髓增殖性肿瘤的临床研究。据了解,JNJ-88549968是一种靶向CALRmut的T细胞重定向双特异性抗体,其通过清除MPN克隆发挥作用。研究人员认为,该产品有望研发成为用于治疗CALRmut MPN的新型双特异性T细胞重定向抗体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"强生(JNJ.US)1类新药在华获批临床 拟开发治疗骨髓增殖性肿瘤","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2133065610.SGD","LU0795875086.SGD","LU0124676726.USD","LU1732800096.USD","LU1066051225.USD","BK4550","IE0001KFT4U8.USD","IE0002141913.USD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","LU2750360997.AUD","LU0787776722.HKD","LU0792757196.USD","LU1894683348.USD","LU0640476718.USD","LU1496350502.SGD","LU0058720904.USD","LU1244550494.USD","BK4559","LU0114720955.EUR","LU1280957306.USD","IE0034235303.USD","LU1929549753.HKD","IE00BJT1NW94.SGD","LU0345769128.USD","IE00B42XCP33.USD","LU1674673691.USD","LU1043141123.HKD","LU2430703251.USD","JNJ","LU2430703095.HKD","LU2602419157.SGD","LU1196500208.SGD","IE00B19Z3581.USD","BK4533","LU2129689514.USD","LU2468319806.SGD","LU0994945656.USD","LU2471134796.USD","LU0098860793.USD","BK4532","BK4585","LU1066051498.USD","IE00BFXG1179.USD","LU1221951046.USD","LU1983299246.USD","IE00BLSP4239.USD","LU2347655156.SGD","LU1894683264.USD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141996053","title":"强生宣布Inlexzo永久性医保编码J码正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1141996053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141996053?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:07","pubTimestamp":1775045235,"startTime":"0","endTime":"0","summary":"强生公司近日宣布,其药物Inlexzo的永久性医疗保健通用程序编码系统(HCPCS)J码现已正式生效。该编码的落地将为医疗报销和药品管理提供标准化流程。\n此次永久性J码的获批,标志着Inlexzo在医保支付体系中获得长期认可,有望提升该药物在临床使用中的可及性。医疗供应商现可通过该编码直接进行费用结算,简化了报销流程。\n强生表示,这一进展体现了公司对优化医疗解决方案的持续承诺,也将为患者获得创新治疗方案提供更多便利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU1914381329.SGD","IE00B19Z3581.USD","BK4585","LU2471134796.USD","IE00BN8TJ469.HKD","LU0985320562.USD","LU0098860793.USD","LU0882574055.USD","IE00B42XCP33.USD","LU1506573853.SGD","LU2430703178.SGD","IE00B19Z3B42.SGD","LU0889566641.SGD","LU1280957306.USD","LU2468319806.SGD","BK4504","BK4533","LU1261432733.SGD","LU0203347892.USD","LU0795875169.SGD","LU1674673428.USD","LU2592432038.USD","IE00BVYPNW00.USD","LU1057294990.SGD","LU2129689605.HKD","LU2129689431.USD","IE00B1BXHZ80.USD","LU2602419157.SGD","LU1221951046.USD","IE0001KFT4U8.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU1935042991.SGD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU2505996681.GBP","IE00BLSP4452.SGD","LU0124676726.USD","LU1894683264.USD","LU1718418525.SGD","LU2430703095.HKD","LU1066051498.USD","LU1032466523.USD","IE000M9KFDE8.USD","IE00B7SZLL34.SGD","LU1066051225.USD","LU2471134879.HKD","LU0640476718.USD","LU0289739699.SGD","LU1061106388.HKD","IE00BBT3K403.USD","LU0058720904.USD","LU2471134952.CNY","IE00BGHQF631.EUR","LU0994945656.USD","LU0787776722.HKD","LU0122379950.USD","LU0345769128.USD","LU1043141396.HKD","BK4581","LU2750360997.AUD","LU1059921491.USD","LU1732800096.USD","LU2505996509.AUD","LU1066051811.HKD","LU1496350502.SGD","BK4559","SG9999002224.SGD","LU0320765646.SGD","IE00B3T34201.USD","LU1043141123.HKD","LU1244550221.USD","LU2471134523.USD","LU0203345920.USD","SG9999002232.USD","BK4534","LU0345769631.USD","LU1221951129.SGD","IE00BSNM7G36.USD","LU0466842654.USD","IE0034235303.USD","LU0795875086.SGD","LU2129689514.USD","LU0234572021.USD","IE0002141913.USD","IE00BLSP4239.USD","LU0912757837.SGD","LU0683600562.USD","IE0002270589.USD","LU1032955483.USD","BK4568","BK4592","LU0426417589.USD","IE00BVYPNV92.GBP","LU0689626769.HKD","IE00BFTCPJ56.SGD","LU2430703251.USD","LU1074936037.SGD","LU2750360641.GBP","BK4007","LU1894683348.USD","BK4588","LU1244550577.SGD","IE00B3PB1722.GBP","SG9999001440.SGD","JNJ","IE00BKVL7J92.USD","LU0345770308.USD","BK4550","LU0234570918.USD","LU0792757196.USD","LU1430594728.SGD","LU1121112475.USD","LU1196500208.SGD","LU0114720955.EUR","LU2089984988.USD","LU2347655156.SGD","LU1778281490.HKD","LU1674673691.USD","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0426412945.USD","LU1162221912.USD","LU1066053197.SGD","LU1244550494.USD","LU1585245621.USD","LU1983299246.USD","LU0345770993.USD","LU0070217475.USD","IE0009355771.USD","BK4532","IE00BJJMRZ35.SGD","LU1267930813.SGD","IE00BJT1NW94.SGD","LU1732799900.SGD","LU1929549753.HKD","IE00BDGV0183.EUR","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112955867","title":"强生Icotyde™(Icotrokinra)一年期数据证实:每日一次银屑病口服药可实现持久皮肤清除且安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1112955867","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112955867?lang=zh_cn&edition=full","pubTime":"2026-03-28 22:03","pubTimestamp":1774706596,"startTime":"0","endTime":"0","summary":"强生公司公布的最新一年期临床研究结果显示,其研发的Icotyde™(Icotrokinra)在治疗斑块型银屑病方面展现出持久的皮肤清除效果与良好的安全特性。该每日一次口服疗法在长期用药过程中持续表现出显著疗效,同时维持了可靠的安全性轮廓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1059921491.USD","LU0795875086.SGD","IE00BVYPNV92.GBP","IE00BFXG1179.USD","LU0345769128.USD","LU1023059063.AUD","LU2430703251.USD","BK4559","IE00BFTCPJ56.SGD","LU1935042991.SGD","LU0795875169.SGD","LU0203345920.USD","LU1066051225.USD","IE00BVYPNW00.USD","LU0466842654.USD","LU2750360997.AUD","IE00BDGV0183.EUR","LU1244550577.SGD","LU1244550221.USD","LU2347655156.SGD","LU1244550494.USD","BK4592","LU1221951046.USD","LU0320765646.SGD","LU0985320562.USD","LU1585245621.USD","LU1674673691.USD","LU1929549753.HKD","IE00BLSP4452.SGD","LU2471134879.HKD","BK4504","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU2471134796.USD","LU1914381329.SGD","BK4568","LU1066051811.HKD","LU2133065610.SGD","LU0912757837.SGD","LU1074936037.SGD","IE00B42XCP33.USD","IE00B3PB1722.GBP","LU1718418525.SGD","LU1196500208.SGD","IE00BN8TJ469.HKD","LU0203347892.USD","IE00B3T34201.USD","SG9999001440.SGD","LU0345770308.USD","BK4532","LU0889566641.SGD","IE00B7SZLL34.SGD","BK4007","LU0882574055.USD","LU1430594728.SGD","IE0001KFT4U8.USD","LU0098860793.USD","LU1983299246.USD","LU1066053197.SGD","LU0070217475.USD","LU2505996681.GBP","LU0289739699.SGD","LU1221951129.SGD","LU2592432038.USD","IE0009355771.USD","LU1732800096.USD","IE00BGHQF631.EUR","LU0432979614.USD","LU2430703178.SGD","LU2505996509.AUD","LU0345770993.USD","LU0792757196.USD","LU1674673428.USD","IE0002141913.USD","IE00BLSP4239.USD","LU1162221912.USD","LU1894683264.USD","LU2471134952.CNY","LU2430703095.HKD","LU2112291526.USD","LU0124676726.USD","LU2089984988.USD","LU1057294990.SGD","LU0114720955.EUR","IE0002270589.USD","IE00BZ1G4Q59.USD","LU1032466523.USD","IE0034235303.USD","BK4533","IE00BSNM7G36.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","SG9999002232.USD","JNJ","LU0122379950.USD","LU0345769631.USD","LU0683600562.USD","LU0689626769.HKD","LU1280957306.USD","IE00B19Z3581.USD","LU2468319806.SGD","BK4550","BK4534","LU1267930813.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU1732799900.SGD","IE00B1BXHZ80.USD","LU2602419157.SGD","LU0234572021.USD","LU1261432733.SGD","BK4585","LU0640476718.USD","LU0234570918.USD","LU2471134523.USD","IE00BJT1NW94.SGD","BK4581","LU1066051498.USD","IE00BKVL7J92.USD","LU1061106388.HKD","LU2129689605.HKD","LU1778281490.HKD","LU1894683348.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1032955483.USD","LU0787776722.HKD","LU1506573853.SGD","LU2129689514.USD","LU1496350502.SGD","LU2129689431.USD","BK4588","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622732570","title":"股价一年暴涨超700%的Nanobiotix(NBTX.US)迎来收购催化 强生(JNJ.US)有意出手","url":"https://stock-news.laohu8.com/highlight/detail?id=2622732570","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622732570?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:04","pubTimestamp":1774440287,"startTime":"0","endTime":"0","summary":"总部位于巴黎的Nanobiotix与全球医疗保健领军者强生目前保持合作关系,双方根据2023年与这家总部位于新泽西州的制药商强生签署的一项长期许可协议,共同开发并商业化其新一代核心资产JNJ-1900。在刚刚过去的2025年,Nanobiotix股价与市值涨幅已超过700%,使其最新的市值达到约15亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1244550577.SGD","LU0203345920.USD","NBTX","IE00B4R5TH58.HKD","IE0009355771.USD","LU1032955483.USD","LU1244550221.USD","IE0001KFT4U8.USD","LU0070217475.USD","BK4139","IE00BFXG1179.USD","IE00B3PB1722.GBP","IE000M9KFDE8.USD","LU1059921491.USD","JNJ","LU2471134879.HKD","BK4534","LU1066051225.USD","LU1894683348.USD","LU1778281490.HKD","IE00BDGV0183.EUR","LU1674673428.USD","LU2430703251.USD","LU0345770993.USD","LU1061106388.HKD","IE00BVYPNW00.USD","LU2089984988.USD","LU0234572021.USD","IE00BJT1NW94.SGD","LU1066051811.HKD","IE0002141913.USD","LU2129689514.USD","LU1162221912.USD","BK4533","LU2471134952.CNY","LU0787776722.HKD","SG9999001440.SGD","LU1929549753.HKD","LU0912757837.SGD","LU2129689431.USD","IE00BZ1G4Q59.USD","LU1267930813.SGD","LU1718418525.SGD","LU0345770308.USD","BK4592","LU1732799900.SGD","BK4585","BK4581","LU2592432038.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.jnj.com;www.investor.jnj.com;www.factsabouttalc.com","stockEarnings":[{"period":"1week","weight":-0.0285},{"period":"1month","weight":-0.0518},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1949},{"period":"1year","weight":0.4684},{"period":"ytd","weight":0.0993}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立,是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品,强调人类的健康和福祉。强生通过两个主要业务部门运营:创新药物和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.00367},{"month":2,"riseRate":0.521739,"avgChangeRate":-0.001555},{"month":3,"riseRate":0.586957,"avgChangeRate":0.015928},{"month":4,"riseRate":0.617021,"avgChangeRate":0.030218},{"month":5,"riseRate":0.478261,"avgChangeRate":-0.025904},{"month":6,"riseRate":0.5,"avgChangeRate":0.005615},{"month":7,"riseRate":0.608696,"avgChangeRate":0.013965},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005146},{"month":9,"riseRate":0.5,"avgChangeRate":0.003517},{"month":10,"riseRate":0.695652,"avgChangeRate":0.021187},{"month":11,"riseRate":0.608696,"avgChangeRate":0.017686},{"month":12,"riseRate":0.652174,"avgChangeRate":0.01226}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}